15:02:36 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Imagin Medical Inc
Symbol IME
Shares Issued 139,060,278
Close 2020-03-09 C$ 0.055
Market Cap C$ 7,648,315
Recent Sedar Documents

Imagin talks doctor feedback on i/Blue system

2020-03-10 08:20 ET - News Release

Mr. Jim Hutchens reports

IMAGIN MEDICAL REPORTS PHYSICIAN FEEDBACK ON I/BLUE(TM) IMAGING SYSTEM FOR BLADDER CANCER VISUALIZATION

Imagin Medical Inc. has provided continuing market research feedback on the i/Blue imaging system, which enables simultaneous viewing of white and blue light images during bladder cancer resection.

Since the American Urological Association (AUA) meeting in May, 2019, where leading urologists observed simulated cystoscopy demonstrations, Imagin has continued to collect additional input on its i/Blue imaging system from physicians in the United States and Canada.

The feedback has focused on the i/Blue's ability to display side-by-side white and blue light images simultaneously, which would enable real-time cancer visualization during resection. Surgeons would no longer need to switch back and forth between the white and blue light images to perform the surgery as the current method requires. This advanced viewing option has the potential to improve surgical technique.

Jim Huchens, the company's president and chief executive officer, commented: "Since beginning our market research at the AUA meeting last May, we have received valuable positive feedback. We look forward to continuing our conversations with urologists at this year's AUA meeting as we move closer to delivering the i/Blue's benefits to the medical community."

About Imagin Medical Inc.

Imagin Medical is a surgical imaging company that is focused on advancing new methods of visualizing cancer during minimally invasive procedures. The company's initial focus is bladder cancer.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.